Gerald Brady is a managing director within SVB’s Venture Capital Group, hired to lead two important initiatives for the company. He is responsible for leading SVB’s Entrepreneur Services Group as well as the company’s work with corporate venture and corporate development groups.
Brady oversees a team dedicated to supporting emerging technology and life science companies, by engaging founders and CEOs with relevant, high-impact programming and networking events to add significant value during their development stages. Brady also maintains and develops relationships with corporate venture and corporate development groups, which the company believes will play an increasingly important role in the venture ecosystem in the future.
Prior to joining SVB, Brady served as the director of investor relations for Siemens AG, where he was responsible for all aspects of investor communications in North America. Before that, Brady was an acquisition director in the Strategic Planning Group at Siemens Corporation, and served as a managing director of Siemens Acceleration USA, which is the early stage venture capital arm of Siemens.
Brady has also worked at 3i in London and Palo Alto, where he was a director, investing in a number of technology businesses, including ActiveCard (ACTI), Bitfone (acquired by HP), Raw Communications (acquired by Thomson Financial) and Winery Exchange. Prior to his work in finance, Brady worked in the Internet and media industry, was part of the UK launch team for ZDNet in 1995, a sales manager for Yahoo! UK when it launched in 1996 and an executive at Ziff-Davis and EMAP Plc.
Brady holds an honors degree from Kingston University, an MBA from Cranfield University and he is a Fellow of the Royal Society of Arts. Brady served as chairman of the NVCA’s Corporate Venture Group from 2006-2007.
Palo Alto (Hanover St.)
United States, Northern California, Central Coast CA, Southern California, Mid Atlantic, Midwest, New England, New York, Pacific Northwest, Rocky Mountain, Southeast, Southwest, Central, Texas, International, Europe, Canada, China, Israel
Life Science, Emerging Technology, Corporate Ventures, Corporate Innovation, Corporate Development
T 650 855 3072